JPS5951948B2 - Rapidly disintegrating chlorinated isocyanuric acid molded product in water - Google Patents

Rapidly disintegrating chlorinated isocyanuric acid molded product in water

Info

Publication number
JPS5951948B2
JPS5951948B2 JP10349580A JP10349580A JPS5951948B2 JP S5951948 B2 JPS5951948 B2 JP S5951948B2 JP 10349580 A JP10349580 A JP 10349580A JP 10349580 A JP10349580 A JP 10349580A JP S5951948 B2 JPS5951948 B2 JP S5951948B2
Authority
JP
Japan
Prior art keywords
water
isocyanuric acid
molded product
chlorinated isocyanuric
disintegration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10349580A
Other languages
Japanese (ja)
Other versions
JPS5728071A (en
Inventor
徳之 谷口
正典 太田
均 笹原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP10349580A priority Critical patent/JPS5951948B2/en
Publication of JPS5728071A publication Critical patent/JPS5728071A/en
Publication of JPS5951948B2 publication Critical patent/JPS5951948B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】 本発明は、水中で迅速かつ微細な崩壊性を示す新規な塩
素化イソシアヌール酸成形物に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel chlorinated isocyanuric acid moldings that exhibit rapid and fine disintegration in water.

従来より、塩素化イソシアヌール酸は、水中で3加水分
解し、塩素を放出する性質を示すために、これを含む殺
菌消毒剤、洗浄剤、漂白剤等として多用されているが、
粉状の形態のものは使用時又は取扱い時に粉立ち易く、
また、計量作業も厄介である等の理由によりー般に好ま
れず、顆粒剤又3は錠剤の形態のものが望まれている。
しかし、塩素化イソシアヌール酸は、常温の水に対する
飽和溶解度が1.2%程度と低いために、単に錠剤を水
中に投入することによつては、迅速に充分量の有効塩素
を水中全体にわたるように供給することができない。そ
こでこれを解決するため従来、水中に錠剤を投入した際
錠剤の崩壊を生起せしめる成分を予め錠剤中に含有させ
ておく提案が知られているが、実用上の問題があり、未
だ充分なものが得られていない。例えば、炭酸ソーダ、
重炭酸ソーダ等の如き発泡作用を発現せしめる物質を錠
剤中に混入しておく方法では、水中で崩壊粒子が微細と
はならず、また、密閉容器中に保存した際にも変質が起
こり易く好ましくない。また、別の例として、ジクロロ
イソシアヌール酸ソーダの無水塩を錠剤中に含めておく
提案(特開昭51−139628号)も知られているが
、この錠剤は保存中に変質し易く、すなわち長期間の保
存中に塩素化イソシアヌール酸の分解が生起し易く、有
効塩素含有率の低下の他に保存容器に損傷をもたらした
り、水中での崩壊性が低下したりする欠点がある。本発
明者らは、塩素化イソシアヌール酸含有錠剤の水中崩壊
性について種々実験的研究を重ねた結果、無水硼酸(B
2O3)及びカルボキシメチルセルロースのカルシウム
塩を含有させた顆粒又は錠剤を水中に投入すると、迅速
に、しかも微細に崩壊が起こり、迅速に塩素が水中全体
にわたつて供給されること、並びに上記顆粒又は錠剤は
通常の密閉容器に保存する保存中に前記の如き変質も起
らず極めて安定に長期間保存できる事実を見出し、本発
明を完成した。
Conventionally, chlorinated isocyanuric acid has been frequently used as a disinfectant, a cleaning agent, a bleaching agent, etc., because it exhibits the property of trihydrolyzing in water and releasing chlorine.
Powdered products tend to crumble during use or handling;
In addition, it is generally not preferred because measuring operations are troublesome, and granules or tablets are desired.
However, because chlorinated isocyanuric acid has a low saturation solubility in water at room temperature of around 1.2%, it is difficult to quickly distribute a sufficient amount of available chlorine throughout the water by simply adding tablets to the water. cannot be supplied as such. In order to solve this problem, there has been a known proposal to pre-contain a component in the tablet that causes the tablet to disintegrate when it is placed in water, but there are practical problems and there is still no sufficient solution. is not obtained. For example, carbonated soda,
A method in which a substance that produces an effervescent effect, such as sodium bicarbonate, is mixed into the tablet is not preferred because the disintegration particles do not become fine in water, and deterioration is likely to occur even when stored in a closed container. Another example is a proposal (Japanese Patent Application Laid-open No. 139628/1983) in which an anhydrous salt of sodium dichloroisocyanurate is included in tablets, but this tablet tends to deteriorate during storage, i.e. Chlorinated isocyanuric acid tends to decompose during long-term storage, which not only reduces the effective chlorine content but also damages storage containers and reduces disintegration in water. As a result of various experimental studies on the disintegration properties in water of tablets containing chlorinated isocyanuric acid, the present inventors found that boric anhydride (B
When granules or tablets containing calcium salts of 2O3) and carboxymethyl cellulose are placed in water, they rapidly and minutely disintegrate, and chlorine is quickly supplied throughout the water, and the granules or tablets mentioned above discovered that the above-mentioned deterioration does not occur during storage in a normal closed container, and that it can be stored extremely stably for a long period of time, and completed the present invention.

本発明の目的は、水中に投入した際、迅速に微細粒にま
で崩壊する塩素化イソシアヌール酸含有の加圧成形物を
提供することにあり、他の目的は密閉容器中に保存した
とき長期間にわたり変質も起らず安定に保存し得る塩素
化イソシアヌール酸含有の加圧成形物を提供することに
ある。
An object of the present invention is to provide a press-molded product containing chlorinated isocyanuric acid that quickly disintegrates into fine particles when placed in water, and another object of the present invention is to provide a press-molded product containing chlorinated isocyanuric acid that quickly disintegrates into fine particles when placed in water. The object of the present invention is to provide a press-molded product containing chlorinated isocyanuric acid that can be stored stably over a period of time without deterioration.

かゝる本発明の水中崩壊性塩素化イソシアヌール酸成形
物は、粉状又は顆粒状の塩素化イソシアヌール酸を主成
分として含有する組成物100重量部と無水硼酸0.3
〜10重量部とカルボキシメチルセルロースのカルシウ
ム塩0.05〜10重量部との混合物を加圧成形してな
ることを特徴とする。本発明に用いられる塩素化イソシ
アヌール酸は、トリクロロイソシアヌール酸、ジクロロ
イソシアヌール酸又はこれらの混合物等てあり、通常、
含水率1%以下の粉状又は顆粒状の工業製品として人手
し得る。本発明に用いられる塩素化イソシアヌール酸を
主成分として含有する組成物としては、上記粉状又は顆
粒状の塩素化イソシアヌール酸、これを主成分とし他の
補助剤、増量剤等補助成分とからなる粉状又は顆粒状の
組成物等であり、上記補助剤、増量剤の例としては、発
泡剤としての無水炭酸ナトリウム及び炭酸水素ナトリウ
ム、成形滑剤としてのオルト硼酸、ステアリン酸ナトリ
ウム増量剤としての食塩、芒硝等が挙げられる。上記塩
素化イソシアヌール酸を主成分として含有する組成物は
粉状又は顆粒状である必要があり、これによつて、本発
明の成形物が水中で崩壊するときは、上記組成物の粉状
又は顆粒状の粒子の大きさにまで崩壊が起こる。従つて
上記組成物の粉末又は顆粒の粒子の大きさは細かい程好
ましいが、通常、20〜1400μ程度で充分である。
The water-disintegrating chlorinated isocyanuric acid molded article of the present invention is made of 100 parts by weight of a composition containing powdered or granular chlorinated isocyanuric acid as a main component and 0.3 parts by weight of boric anhydride.
It is characterized by being formed by pressure molding a mixture of ~10 parts by weight and 0.05 to 10 parts by weight of calcium salt of carboxymethyl cellulose. The chlorinated isocyanuric acid used in the present invention is trichloroisocyanuric acid, dichloroisocyanuric acid, or a mixture thereof, and usually,
It can be manufactured by hand as a powder or granule industrial product with a water content of 1% or less. The composition containing chlorinated isocyanuric acid as a main component used in the present invention includes the above-mentioned powder or granular chlorinated isocyanuric acid, and other auxiliary agents, fillers, and other auxiliary ingredients. Examples of the above-mentioned auxiliary agents and fillers include anhydrous sodium carbonate and sodium bicarbonate as blowing agents, orthoboric acid as a molding lubricant, and sodium stearate as a filler. Examples include common salt, mirabilite, etc. The composition containing the above-mentioned chlorinated isocyanuric acid as a main component must be in the form of powder or granules. Alternatively, disintegration occurs down to the size of granular particles. Therefore, the particle size of the powder or granules of the above composition is preferably as small as possible, but a particle size of about 20 to 1400 microns is usually sufficient.

本発明に用いられる無水硼酸は、化学式B2O3で示さ
れ、通常、70〜300μ程度の微粉状の工業製品であ
る。この無水硼酸は、本発明の成形物において、これが
水中に投入され水との接触が起つた際、成形物を強力に
崩壊せしめる作用を示し、水分、空気等を遮断できる通
常の密閉式容器中に本発明の成形物を保存するとき、成
形物の変質を防止し長期間にわたり安定に成形物を維持
せしめる作用をする。一方、この無水硼酸を含有しない
塩素化イソシアヌール酸含有成形物は、水分、空気等を
遮断できる通常の密閉式容器、例えば、金属製容器、プ
ラスチツク製袋等の中に保存しても、塩素化イソシアヌ
ール酸の分解が徐々に進行し、蓄積した分解ガスによつ
て容器の損傷腐蝕等が起つたり、容器の開封時に作業者
は被害をこうむつたりするのに対し、驚くべきことに本
発明の塩素化イソシアヌール酸自有成形物では、か\る
問題を全く生起せしめない。本発明に用いられるカルボ
キシメチルセルロースのカルシウム塩は、通常、重合度
50〜1000程度で、置換度0.2以上のカルボキシ
メチルロースのCa塩(以下、Ca−CMCと符号す。
Boric anhydride used in the present invention is represented by the chemical formula B2O3, and is usually an industrial product in the form of a fine powder of about 70 to 300 microns. This boric anhydride has the effect of strongly disintegrating the molded product of the present invention when it is placed in water and comes into contact with water. When storing the molded product of the present invention, it acts to prevent deterioration of the molded product and maintain the molded product stably for a long period of time. On the other hand, molded products containing chlorinated isocyanuric acid that do not contain boric anhydride do not contain chlorinated The decomposition of isocyanuric acid progresses gradually, and the accumulated decomposed gas can cause damage to the container, cause corrosion, and workers may suffer damage when opening the container. The chlorinated isocyanuric acid-proprietary molded product of the present invention does not cause such problems at all. The calcium salt of carboxymethyl cellulose used in the present invention usually has a degree of polymerization of about 50 to 1000 and a degree of substitution of 0.2 or more.

)であり、このものは水不溶性を示し、白色の粒径20
〜200μ程度の粉末が好ましい。このCa一CMCも
、本発明の塩素化イソシアヌール酸自有成形物に、これ
を密閉式容器中に保存したとき、成形物の変質を防止し
長期間にわたる安定性をもたらすと共に、水中において
水と接触させたときは成形物を速やかに崩壊せしめる作
用をする。本発明の塩素化イソシアヌール酸含有成形物
は、前記塩素化イソシアヌール酸含有組成物とこれに対
し0.3〜10%量の上記無水硼酸及び0.05〜10
%量の上記Ca−CMCとの混合物を加圧成形すること
により得られる。混合は通常の混合機により容易に行な
われ、均一な程良好であり、水中に成形物が投入された
とき均一な崩壊を生起せしめる。もちろん、上記混合に
おいて、本発明の目的が達成される限り、他の任意の成
分を混合してよい。例えば、成形滑剤としてステアリン
酸ナトリウムを少量加えると、成形性の良好な混合物が
得られる。上記混合において、無水硼酸の混合比率0.
3以下では、得られた成形物を水中に投入したとき、成
形物全体にわたる迅速かつ微細粒子状の崩壊が起りにく
\なり、また密閉容器中の保存に際しても充分な安定化
効果をもたらさない。無水硼酸はその混合比率が高い程
その効果を発現せしめるが、10%以上にも高比率に混
合することは、その割には上記効果に差異が現われず、
成形物中の塩素化イソシアヌール酸の含有率が低下し、
実用上好ましくない。Ca−CMCについても、上記と
同様の理由によつて、その混合比率としては0.05〜
10%が好ましい。本発明における驚くべき効果は、上
記無水硼酸とCa−CMCの両成分とが相剰的に作用し
て、成形物を水中において著しく短時間に崩壊せしめる
効果である。例えば、前記塩素化イソシアヌール酸含有
組成物100重量部に、無水硼酸のみを4重量部混合し
て得られる錠剤は、水中で完全に崩壊せしめるに要する
時間が5分11秒であり、また、Ca一CMCのみを4
重量部混合して得られる錠剤では、水中で完全に崩壊せ
しめるに要する時間が2分17秒であるのに対し、無水
硼酸2重量部とCa{MC2重量部とを混合して得られ
る本発明の錠剤は、水中で完全に崩壊するのにわずか5
9秒しか要しない。かゝる相剰効果を発現せしめるには
、無水硼酸とCa−CMCとの混合比率として、無水硼
酸1重量部に対しCa− CMCO.l〜 5.0重量
部、特に0.3〜 3.0重量部が好ましい。成形物中
における無水硼酸及びCa−CMCの混合比率が低下す
る程、水中で成形物全体が崩壊するに要する時間は長び
き、無水硼酸とCa−CMC両者の合計混合比率が塩素
化イソシアヌール酸に対し0.3%以下では、得られた
成形物は水中で表面から逐次崩壊し、崩壊粒が水中に剥
落する現象が生起するので、長時間にわたり逐次塩素化
イソシアヌール酸の微粒子を水中に供給したい用途、例
えば、汚水の流水中に少しずつ供給したときには、かゝ
る低混合比率の錠剤を汚流水中に浸漬する方法により、
その目的が達成されるので、かゝる低混合比率の成形物
も用いることができる。しかし、通常、上記特殊な用途
を除いては、成形物全体が迅速に崩壊することが望まれ
る。本発明の塩素化イソシアヌール酸含有成形物は、上
記混合によつて得られる混合物を加圧成形することによ
り得られる。
), which is water-insoluble and has a white particle size of 20
A powder of about 200 μm is preferable. This Ca-CMC also prevents deterioration of the molded product and provides long-term stability to the chlorinated isocyanuric acid-proprietary molded product of the present invention when stored in a closed container. When it comes into contact with it, it acts to quickly disintegrate the molded product. The chlorinated isocyanuric acid-containing molded article of the present invention comprises the chlorinated isocyanuric acid-containing composition, the boric anhydride in an amount of 0.3 to 10%, and 0.05 to 10% of the composition.
% of the above Ca-CMC. Mixing is easily carried out using a conventional mixer, and the more uniform the better, resulting in uniform disintegration when the molded product is placed in water. Of course, in the above mixing, other arbitrary components may be mixed as long as the purpose of the present invention is achieved. For example, if a small amount of sodium stearate is added as a molding lubricant, a mixture with good moldability can be obtained. In the above mixing, the mixing ratio of boric anhydride is 0.
If it is less than 3, when the obtained molded product is placed in water, rapid and fine particle disintegration is difficult to occur throughout the molded product, and it does not have a sufficient stabilizing effect when stored in a closed container. . The higher the mixing ratio of boric anhydride, the more effective it becomes, but when it is mixed at a ratio as high as 10% or more, there is no difference in the above effects.
The content of chlorinated isocyanuric acid in the molded product decreases,
Practically unfavorable. Regarding Ca-CMC, for the same reason as above, the mixing ratio is 0.05~
10% is preferred. A surprising effect of the present invention is that both the boric anhydride and Ca-CMC components act mutually to cause the molded product to disintegrate in water in an extremely short time. For example, a tablet obtained by mixing only 4 parts by weight of boric anhydride with 100 parts by weight of the chlorinated isocyanuric acid-containing composition takes 5 minutes and 11 seconds to completely disintegrate in water; Ca-CMC only 4
The tablet obtained by mixing 2 parts by weight of boric anhydride and 2 parts by weight of Ca{MC takes 2 minutes and 17 seconds to completely disintegrate in water, whereas the tablet obtained by mixing 2 parts by weight of boric anhydride with 2 parts by weight of Ca{MC tablet takes only 5 minutes to completely disintegrate in water.
It only takes 9 seconds. In order to produce such a mutually beneficial effect, the mixing ratio of boric anhydride and Ca-CMC should be 1 part by weight of boric anhydride to 1 part by weight of Ca-CMCO. It is preferably 1 to 5.0 parts by weight, particularly 0.3 to 3.0 parts by weight. As the mixing ratio of boric anhydride and Ca-CMC in the molded product decreases, the time required for the entire molded product to disintegrate in water becomes longer, and the total mixing ratio of both boric anhydride and Ca-CMC decreases to chlorinated isocyanuric acid. However, if the concentration is less than 0.3%, the obtained molded product will gradually disintegrate from the surface in water, and the disintegrated particles will peel off into the water. For example, when the tablets are to be supplied little by little into flowing sewage, the method of immersing tablets with such a low mixing ratio in sewage water can
Since that purpose is achieved, moldings with such low mixing ratios can also be used. However, except for the special uses mentioned above, it is generally desired that the entire molded product disintegrates quickly. The chlorinated isocyanuric acid-containing molded article of the present invention is obtained by pressure molding the mixture obtained by the above mixing.

成形物の形状は、用途目的に応じ任意でよく、また、通
常の加圧成形法により成形できるものでよい。例えば、
打錠機により得られる径1〜 5(:7RL、高さ0.
5〜5cm程度の錠剤、コン′ゞクトマシンによつて得
られる厚さ1〜3m1程度の板状物若しくはこれを砕い
て得られるフレーク状品が挙げられる。加圧成形は、打
錠の場合では、100〜800kg/(−JモVF程度が
好ましい。打錠圧が50kg/Cil以下では、成形錠
剤を取り扱う際又は保存輸送中に形状がくずれ易く、ま
た、900kg/Cil以上の圧力は不要であり、余計
なエネルギー損失を招く。コン′ゞクトマシンによる場
合では、300〜3000kg/露”程度の圧力が上記
と同様の理由によつて好ましい。かくして得られる本発
明の塩素化イソシアヌール酸含有成形物は、通常、一旦
プラスチツク製容器、袋等の中に密封され、必要に応じ
更に例えば段ボール箱、金属製容器等の中に保存される
が、長期間にわたり、変質が起ることもなく、開封して
水中に投入するときは、速やかにすなわち通常、2分以
内に全体崩壊が起こり微細に崩壊した塩素化イソシアヌ
ール酸の粒子は、水の揺動があるときは更に分散が起こ
り、溶解と加水分解によつて水中全体にわたり塩素の供
給が速やかに達成される。
The shape of the molded product may be arbitrary depending on the purpose of use, and may be one that can be molded by a normal pressure molding method. for example,
Diameter 1 to 5 (: 7RL, height 0.
Tablets with a size of about 5 to 5 cm, plate-shaped products with a thickness of about 1 to 3 ml obtained by using a contact machine, or flake-shaped products obtained by crushing the same can be mentioned. In the case of tableting, pressure molding is preferably about 100 to 800 kg/(-JmoVF. If the tableting pressure is less than 50 kg/Cil, the shape of the molded tablet is likely to collapse during handling or storage/transportation. , a pressure of 900 kg/Cil or more is unnecessary and causes unnecessary energy loss. When using a contact machine, a pressure of about 300 to 3000 kg/Cil is preferable for the same reason as above. The chlorinated isocyanuric acid-containing molded article of the present invention is usually once sealed in a plastic container, bag, etc., and if necessary, further stored in a cardboard box, metal container, etc., for a long period of time. For a long period of time, no deterioration occurs, and when the package is opened and put into water, the whole disintegrates quickly, usually within 2 minutes, and the finely disintegrated chlorinated isocyanuric acid particles are absorbed by the shaking of the water. In some cases, further dispersion occurs and a rapid supply of chlorine throughout the water is achieved by dissolution and hydrolysis.

本発明の塩素化イソシアヌール酸含有成形物は、汚水の
浄化、水泳用プールの殺菌消毒、食器類等洗浄水の殺菌
消毒用等に有用である。以下、参考例、実施例及び比較
例を挙げて更に詳しく説明するが、本発明の技術的範囲
はこれによつて制限されるものではない。
The chlorinated isocyanuric acid-containing molded article of the present invention is useful for purifying sewage, sterilizing swimming pools, sterilizing water for washing dishes, etc. The present invention will be described in more detail below with reference to Reference Examples, Examples, and Comparative Examples, but the technical scope of the present invention is not limited thereby.

先ず、水中崩壊性の試験法と保存安定性の試験法を説明
する。
First, the test method for disintegration in water and the test method for storage stability will be explained.

試験法A (錠剤の水中崩壊性試験) 内径40□l)高さ55属lのポリ塩化ビニル製円筒の
上部及び下部に網目8メツシユのステンレス製金網を底
網及び蓋網としてとりつけた容器中に、1箇30gの試
料錠剤を内容し、これを25℃の11の水が入つた大型
ビーカー中に保持具を介して懸垂し、直ちに30回/分
の割合で、水中振巾50m罵の上下運動を起させること
により崩壊粒を網を通して容器外に脱落せしめ、全量が
網の外へ脱落するに要する時間を測定する。
Test method A (Tablet disintegration test in water) In a container made of a polyvinyl chloride cylinder with an inner diameter of 40 □l and a height of 55 mm, stainless steel wire meshes with 8 meshes were attached to the top and bottom as the bottom mesh and lid mesh. A sample tablet weighing 30 g was suspended in a large beaker containing water at 25°C via a holder, and immediately shaken at a rate of 30 times/min with an underwater shaking width of 50 m. The disintegrated particles are caused to fall out of the container through the screen by vertical movement, and the time required for the entire amount to fall out of the screen is measured.

試験法B (顆粒品の水中崩壊性試験) 〜上記試験法Aにおける錠剤内容容器の代りに内径12
(V7z、高さ15舅露のポリ塩化ビニル製円筒の上部
及び下部に網目40メツシユのステンレス製金網を底網
及び蓋網としてとりつけた容器を用い、これに19量の
試験顆粒を内容させ、上記試験法Aと同様にして全量が
網の外へ脱落するに要する時間を測定する。
Test method B (disintegratability test of granules in water) ~Instead of the tablet container in test method A above, an inner diameter of 12
(V7z, a container made of polyvinyl chloride with a height of 15 mm and stainless steel wire mesh with 40 meshes attached to the top and bottom as the bottom mesh and lid mesh, was used, and 19 amounts of test granules were placed in it, The time required for the entire amount to fall out of the net is measured in the same manner as in Test Method A above.

試験法C (成形物の保存安定性試験) 内容積500ゴの三つ口ガラス製容器内に顆粒の場合3
01、錠剤では1錠(301)試利を投入し、第10を
ゴム栓により封口し、第20および第30に弁付ガラス
栓を取り付け、閉弁状態とし、35℃の恒温室で10日
間静置保存する。
Test method C (Storage stability test for molded products) 3 for granules in a three-necked glass container with an internal volume of 500 g
01. For tablets, put one tablet (301) trial sample, seal No. 10 with a rubber stopper, attach glass stoppers with valves to No. 20 and No. 30, close the valves, and store in a constant temperature room at 35 ° C for 10 days. Store it still.

その後、第20に乾燥窒素ガスの導管を連結し、第30
に50ゴの0.5苛性ソーダー水溶液に通する導管を連
結し、上記保存期間の終了後直ちに両弁共に開き、第2
0から乾燥窒素を導入し、第30よりの排気を苛性ソー
ダ水溶液に導き、分解発生ガスを吸収せしめた。通気を
行つた後、苛性ソーダ水溶液によう化カリウム0.22
を加え、酢酸酸性条件下で百分の1規定のチオ硫酸ナト
リウム水溶液によりでんぷんを指示薬として滴定し、苛
性ソーダ水溶液に吸収された有効塩素量を求めた。この
有効塩素量をもつてトリクロロイソシアヌル酸から発生
する塩素ガスと塩素窒素ガスの合量とした。参考例 1 含水率0.3%粒径50〜100μのトリクロロイソシ
アヌール酸粉末を、油圧ロール式乾燥造粒機を用いて、
圧縮圧1500kg/Cmで厚み2關の板状に成形した
後破砕し、更に10メツシユと32メツシユで篩分する
ことにより、粒径10〜32メツシユのフレーク状顆粒
を得た。
After that, a dry nitrogen gas conduit is connected to the 20th pipe, and the 30th pipe is connected to the dry nitrogen gas conduit.
A conduit for passing 50 g of 0.5 caustic soda aqueous solution is connected to the valve, and immediately after the above storage period, both valves are opened, and the second valve is opened.
Dry nitrogen was introduced from No. 0, and exhaust gas from No. 30 was introduced into a caustic soda aqueous solution to absorb decomposition gas. After aeration, add 0.22% potassium iodide to the caustic soda aqueous solution.
was added and titrated with a 1/100 normal sodium thiosulfate aqueous solution under acetic acid acidic conditions using starch as an indicator to determine the amount of available chlorine absorbed in the caustic soda aqueous solution. This effective chlorine amount was taken as the total amount of chlorine gas and chlorine nitrogen gas generated from trichloroisocyanuric acid. Reference Example 1 Trichloroisocyanuric acid powder with a moisture content of 0.3% and a particle size of 50 to 100 μm was processed using a hydraulic roll drying granulator.
The mixture was molded into a plate shape with a thickness of 2 mm under a compression pressure of 1500 kg/cm, then crushed, and further sieved through 10 mesh and 32 mesh to obtain flaky granules with a particle size of 10 to 32 mesh.

次いで得られた顆粒について、前記試験法B及びCに従
つて、水中崩壊性及び保存安定性を試験した結果第1表
記載の結果を得た。参考例 2 参考例1におけるトリクロロイソシアヌール酸の代りに
、自水率0.7%、粒径50〜100μのジクロロイソ
シアヌール酸を用いた他は、参考例:1と同様にして顆
粒に成形し、更に水中崩壊性及び保存安定性を試験し第
1表記載の結果を得た。
The obtained granules were then tested for disintegration in water and storage stability according to Test Methods B and C, and the results shown in Table 1 were obtained. Reference Example 2 Molded into granules in the same manner as Reference Example 1, except that dichloroisocyanuric acid with a water content of 0.7% and a particle size of 50 to 100 μm was used instead of trichloroisocyanuric acid in Reference Example 1. Furthermore, the disintegration properties in water and storage stability were tested, and the results shown in Table 1 were obtained.

参考例 3参考例1において得られた顆粒と、これに対
し0.2%量の含水率0.6%、粒径20〜70μの成
形滑剤ステアリン酸ナトリウムとの混合物を、ロータリ
ー式連続打錠機により打錠圧300kg/Crlで打錠
し、1箇の重量301、径351Em、高さ17鼎の円
板状のトリクロロイソシアヌール酸錠剤を得た。
Reference Example 3 A mixture of the granules obtained in Reference Example 1 and sodium stearate, a molding lubricant, with a water content of 0.6% and a particle size of 20 to 70μ in an amount of 0.2% was subjected to rotary continuous tableting. The tablets were compressed using a machine at a tableting pressure of 300 kg/Crl to obtain one disc-shaped trichloroisocyanuric acid tablet having a weight of 301 cm, a diameter of 351 Em, and a height of 17 cm.

この錠剤について、前記試験法A及びCに従つて水中崩
壊性及び保存安定性を試験したところ第1表記載の結果
を得た。参考例 4 参考例1において得られた顆粒の代りに、参考例2にお
いて得られた顆粒を用いた他は、参考例3と同様にして
ジクロロイソシアヌール酸錠剤を得、更に水中崩壊性及
び保存安定性を試験し第1表記載の結果を得た。
When this tablet was tested for disintegration in water and storage stability according to Test Methods A and C, the results shown in Table 1 were obtained. Reference Example 4 Dichloroisocyanuric acid tablets were obtained in the same manner as Reference Example 3, except that the granules obtained in Reference Example 2 were used instead of the granules obtained in Reference Example 1, and the disintegration in water and storage were further evaluated. The stability was tested and the results shown in Table 1 were obtained.

同表に示す如く、これら参考例1〜4の顆粒及び錠剤は
いずれも保存安定性が悪く、密閉容器中でもかなりの量
の分解塩素の放出が認められ、また、水中では崩壊する
ことなく、それら成形物の表面かられずかに塩素化イソ
シアヌール酸の溶解が起るのみである。
As shown in the table, the granules and tablets of Reference Examples 1 to 4 all had poor storage stability, releasing a considerable amount of decomposed chlorine even in closed containers, and did not disintegrate in water. Dissolution of chlorinated isocyanuric acid only occurs from the surface of the molded product.

実施例 1〜7 参考例1に用いたものと同じトリクロロイソシアヌール
酸粉末と粒径70〜120μの無水硼酸粉末と自水率4
.5%、粒径30〜60μのCa一CMC粉末とを第2
表記載の比率で混合した後、参考例1と同様にして顆粒
に成形し、更に水中崩壊性と保存安定性を試験したとこ
ろ、第2表記載の結果を得た。
Examples 1 to 7 The same trichloroisocyanuric acid powder used in Reference Example 1, boric anhydride powder with a particle size of 70 to 120μ, and self-hydration rate 4
.. 5% Ca-CMC powder with a particle size of 30 to 60μ
After mixing in the ratios listed in the table, they were formed into granules in the same manner as in Reference Example 1, and further tested for disintegration in water and storage stability, and the results listed in Table 2 were obtained.

実施例 8〜10 実施例1におけるトリクロロイソシアヌール酸の代りに
、参考例2に用いたものと同じジクロロイソシアヌール
酸を用いた他は実施例1と同様にして顆粒に成形し、水
中崩壊性と保存安定性を試験したところ、第2表記載の
結果を得た。
Examples 8 to 10 Granules were formed in the same manner as in Example 1, except that the same dichloroisocyanuric acid used in Reference Example 2 was used instead of trichloroisocyanuric acid in Example 1. When the storage stability was tested, the results shown in Table 2 were obtained.

実施例 11〜15 上記実施例に用いたものと同じトリクロロイソシアヌー
ル酸粉末又はジクロロイソシアヌール酸粉末と無水硼酸
、Ca−CMC及び含水率0.6%、粒径20〜70μ
のステアリン酸ナトリウムを第3表記載の比率で混合し
た後、参考例3と同様の打錠法により、錠剤を得、更に
水中崩壊性及び保存安定性を試験したところ、第3表所
載の結果を得た。
Examples 11-15 The same trichloroisocyanuric acid powder or dichloroisocyanuric acid powder as used in the above examples, boric anhydride, Ca-CMC, water content 0.6%, particle size 20-70μ
After mixing sodium stearate in the proportions listed in Table 3, tablets were obtained by the same tableting method as in Reference Example 3, and further tested for disintegration in water and storage stability. Got the results.

実施例 16〜20 含水率0.6%、粒径20〜70μのステアリン酸ナト
リウムを、上記実施例1〜9において得られた顆粒にそ
の0.2%量宛混合し、参考例3に記載の打錠法に従つ
て錠剤に成形し、更に水中崩壊性と保存安定性を試験し
たところ、第4表の結果を得た。
Examples 16 to 20 Sodium stearate having a water content of 0.6% and a particle size of 20 to 70μ was mixed into the granules obtained in Examples 1 to 9 above in an amount of 0.2%, and the mixture was prepared as described in Reference Example 3. The tablets were formed into tablets according to the tableting method described in Table 4, and further tested for disintegration in water and storage stability, and the results shown in Table 4 were obtained.

実施例 21及び22 参考例1において得られたトリクロロイソシアヌール酸
顆粒に、上記実施例に用いたものと同じ無水硼酸、Ca
−CMC及びステアリン酸ナトリウムを第5表記載の比
率で混合した後、参考例3と同様にしてトリクロロイソ
シアヌール酸錠剤を得、更に水中崩壊性及び保存安定性
を試験したところ、第5表記載の結果を得た。
Examples 21 and 22 The same boric anhydride and Ca as used in the above example were added to the trichloroisocyanuric acid granules obtained in Reference Example 1.
- After mixing CMC and sodium stearate in the ratio shown in Table 5, a trichloroisocyanuric acid tablet was obtained in the same manner as in Reference Example 3, and further tested for disintegration in water and storage stability. The results were obtained.

ヒ実施例 23及び24 実施例20におけるトリクロロイソシアヌール酸顆粒の
代りに、参考例2において得られたジクロロイソシアヌ
ール酸顆粒を用いた他は実施例21と同様にしてジクロ
ロイソシアヌール酸錠剤を得、更に水中崩壊性及び保存
安定性を試験したところ第5表記載の結果を得た。
Examples 23 and 24 Dichloroisocyanuric acid tablets were obtained in the same manner as in Example 21, except that the dichloroisocyanuric acid granules obtained in Reference Example 2 were used instead of the trichloroisocyanuric acid granules in Example 20. Furthermore, when the disintegration property in water and the storage stability were tested, the results shown in Table 5 were obtained.

比較例 1〜7 参考例1に用いたものと同じトリクロロイソシアヌール
酸粉末に、含水率0.7%、粒径50〜100μのジク
ロロイソシアヌール酸ナトリウムの無水塩、実施例に用
いたものと同じ無水硼酸又はCa−CMCを第6表記載
の比率で混合した後、参考例1と同様にして顆粒に成形
し、更に水中崩壊性及び保存安定性を試験したところ、
第6表記載の結果を得た。
Comparative Examples 1 to 7 To the same trichloroisocyanuric acid powder as that used in Reference Example 1, anhydrous salt of sodium dichloroisocyanurate having a water content of 0.7% and a particle size of 50 to 100 μ, and the same as that used in the example were added. After mixing the same boric anhydride or Ca-CMC at the ratio listed in Table 6, it was formed into granules in the same manner as in Reference Example 1, and further tested for disintegration in water and storage stability.
The results listed in Table 6 were obtained.

無水硼酸及びCa−CMCを混合して得られた前記実施
例の成形物に対し、同水準の無水硼酸又はCa−CMC
の混合比率の比較例成形物はいずれも水中崩壊性が劣る
。比較例 8及び9 比較例1におけるトリクロロイソシアヌール酸の代りに
、参考例2に用いたものと同じジクロロイソシアヌール
酸粉末を用いた他は比較例3及び6と同様にして顆粒に
成形し、水中崩壊性及び保存安定性を試験したところ、
第6表記載の結果を得た。
For the molded product of the above example obtained by mixing boric anhydride and Ca-CMC, the same level of boric anhydride or Ca-CMC was mixed.
Comparative molded products with a mixing ratio of are all poor in disintegration in water. Comparative Examples 8 and 9 Molded into granules in the same manner as Comparative Examples 3 and 6 except that the same dichloroisocyanuric acid powder as that used in Reference Example 2 was used instead of trichloroisocyanuric acid in Comparative Example 1, When tested for disintegration in water and storage stability,
The results listed in Table 6 were obtained.

比較例 10及び11 参考例1に用いたものと同じトリクロロイソシアヌール
酸粉末に、これに対し前記と同じ無水硼酸又はCa−C
MCを4%及びステアリン酸ナトリウムを0.2%混合
した後、参考例3における打錠法により、飽剤に成形し
水中崩壊性及び保存安定性を試験したところ、第7表記
載の結果を得た。
Comparative Examples 10 and 11 The same trichloroisocyanuric acid powder as used in Reference Example 1 was added with the same boric anhydride or Ca-C as described above.
After mixing 4% MC and 0.2% sodium stearate, it was formed into a saturated tablet using the tableting method in Reference Example 3 and tested for disintegration in water and storage stability, and the results shown in Table 7 were obtained. Obtained.

比較例 12〜15参考例1及び2において得られた顆
粒に、これに対し0.2%量の前記と同じステアリン酸
ナトリウムと前記と同じ無水硼酸又はCa−CMCとを
第8表記載の比率で混合した後参考例3の打飽法により
錠剤に成形し、更に水中崩壊性と保存安定性を試験した
ところ、第8表記載の結果が得られた。
Comparative Examples 12 to 15 To the granules obtained in Reference Examples 1 and 2, 0.2% of the same sodium stearate as above and the same boric anhydride or Ca-CMC as above were added in the ratio shown in Table 8. After mixing, the mixture was formed into tablets by the saturation method of Reference Example 3, and further tested for disintegration in water and storage stability, and the results shown in Table 8 were obtained.

比較例 16〜20 比較例3,5,6,8又は9において得られた顆粒に、
これに対し0.2%量の前記と同じステアリン酸ナトリ
ウムを混合した後、参考例3の打錠法と同様にして打錠
し、得られた錠剤について水中崩壊性及び保存安定性を
試験したところ、第8表記載の結果を得た。
Comparative Examples 16 to 20 The granules obtained in Comparative Examples 3, 5, 6, 8 or 9,
After mixing 0.2% of the same sodium stearate as above, it was compressed into tablets in the same manner as in Reference Example 3, and the resulting tablets were tested for disintegration in water and storage stability. However, the results shown in Table 8 were obtained.

Claims (1)

【特許請求の範囲】[Claims] 1 粉状又は顆粒状の塩素化イソシアヌール酸を主成分
として含有する組成物100重量部と無水硼酸0.3〜
10重量部とカルボキシメチルセルロースのカルシウム
塩0.05〜10重量部との混合物を加圧成形してなる
ことを特徴とする水中迅速崩壊性塩素化イソシアヌール
酸成形物。
1 100 parts by weight of a composition containing powdered or granular chlorinated isocyanuric acid as a main component and 0.3 to 0.3 to boric anhydride
1. A rapidly disintegrating chlorinated isocyanuric acid molded product, characterized in that it is formed by pressure molding a mixture of 10 parts by weight of calcium salt of carboxymethyl cellulose and 0.05 to 10 parts by weight of calcium salt of carboxymethyl cellulose.
JP10349580A 1980-07-28 1980-07-28 Rapidly disintegrating chlorinated isocyanuric acid molded product in water Expired JPS5951948B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10349580A JPS5951948B2 (en) 1980-07-28 1980-07-28 Rapidly disintegrating chlorinated isocyanuric acid molded product in water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10349580A JPS5951948B2 (en) 1980-07-28 1980-07-28 Rapidly disintegrating chlorinated isocyanuric acid molded product in water

Publications (2)

Publication Number Publication Date
JPS5728071A JPS5728071A (en) 1982-02-15
JPS5951948B2 true JPS5951948B2 (en) 1984-12-17

Family

ID=14355567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10349580A Expired JPS5951948B2 (en) 1980-07-28 1980-07-28 Rapidly disintegrating chlorinated isocyanuric acid molded product in water

Country Status (1)

Country Link
JP (1) JPS5951948B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323201U (en) * 1986-07-28 1988-02-16
JPH03204802A (en) * 1989-10-06 1991-09-06 Shikoku Chem Corp Macrobiotic agent for cut flower and method for treating cut flower

Also Published As

Publication number Publication date
JPS5728071A (en) 1982-02-15

Similar Documents

Publication Publication Date Title
US5021186A (en) Chloroisocyanuric acid composition having storage stability
KR101424827B1 (en) Chlorine dioxide based cleaner/sanitizer
US3342674A (en) Sterilizing, sanitizing, and/or disinfecting shapes
JPS5951948B2 (en) Rapidly disintegrating chlorinated isocyanuric acid molded product in water
JPH036142B2 (en)
JPS6232747B2 (en)
JPS5930879A (en) Frothing molded product
US5660821A (en) Extended-release chemical formulation in tablet form for urine pretreatment
US5230903A (en) Chloroisocyanurate composition
US5244644A (en) Process for improving the storage stability of percarbonate and percarbonate composition produced thereby
US7651628B2 (en) Compression molded product of effervescent chlorinated isocyanuric acid
JPH0472804B2 (en)
JPH0118903B2 (en)
JPS6363526B2 (en)
CN113812419A (en) Chlorine dioxide effervescent disinfecting tablet
JP4356970B2 (en) Fast-soluble chlorinated isocyanuric acid moldings
JPS6141487B2 (en)
JP2535975B2 (en) Molding composition for water treatment
JPS642563B2 (en)
JP2643199B2 (en) Chloroisocyanurate composition
JP2606267B2 (en) Sterilizing / bleaching tablets
JPS60112714A (en) Production of foamable granular composition having storage stability
JPH0543407A (en) Quickly soluble formed material of chlorinated isocyanuric acid
JP2711983B2 (en) Disinfection tablets
JPH0335359B2 (en)